- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 4.20 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x PRO- LEU- PHE- ASN- PHE- MSE- GLY: CED-3 fragment(Non-covalent)
- 8 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 5 residues within 4Å:- Chain A: S.166, K.191, D.250, D.251
- Ligands: ATP.4
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:S.166, A:D.250
MG.5: 5 residues within 4Å:- Chain B: S.166, D.250, D.251, T.271
- Ligands: ATP.6
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:S.166, B:D.250
MG.9: 5 residues within 4Å:- Chain C: S.166, K.191, D.250, D.251
- Ligands: ATP.10
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:S.166, C:D.250
MG.11: 5 residues within 4Å:- Chain D: S.166, D.250, D.251, T.271
- Ligands: ATP.12
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:S.166, D:D.250
MG.15: 5 residues within 4Å:- Chain E: S.166, K.191, D.250, D.251
- Ligands: ATP.16
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:S.166, E:D.250
MG.17: 5 residues within 4Å:- Chain F: S.166, D.250, D.251, T.271
- Ligands: ATP.18
2 PLIP interactions:2 interactions with chain F- Metal complexes: F:S.166, F:D.250
MG.21: 5 residues within 4Å:- Chain G: S.166, K.191, D.250, D.251
- Ligands: ATP.22
2 PLIP interactions:2 interactions with chain G- Metal complexes: G:S.166, G:D.250
MG.23: 5 residues within 4Å:- Chain H: S.166, D.250, D.251, T.271
- Ligands: ATP.24
2 PLIP interactions:2 interactions with chain H- Metal complexes: H:S.166, H:D.250
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.4: 21 residues within 4Å:- Chain A: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, D.251, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.3
13 PLIP interactions:13 interactions with chain A- Hydrogen bonds: A:Y.131, A:G.162, A:S.163, A:G.164, A:K.165, A:S.166, A:V.167, A:Q.171, A:Y.305, A:Y.369
- Salt bridges: A:K.165, A:K.165, A:R.273
ATP.6: 21 residues within 4Å:- Chain B: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, D.251, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.5
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:Y.131, B:G.162, B:G.164, B:K.165, B:S.166, B:V.167, B:Q.171, B:Y.305, B:Y.369
- Salt bridges: B:K.165, B:K.165, B:R.273
- pi-Stacking: B:F.301
ATP.10: 21 residues within 4Å:- Chain C: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, D.251, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.9
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:Y.131, C:G.162, C:S.163, C:G.164, C:K.165, C:S.166, C:V.167, C:Q.171, C:Y.305, C:Y.369
- Salt bridges: C:K.165, C:K.165, C:R.273
ATP.12: 21 residues within 4Å:- Chain D: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, D.251, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.11
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:Y.131, D:G.162, D:G.164, D:K.165, D:S.166, D:V.167, D:Q.171, D:Y.305, D:Y.369
- Salt bridges: D:K.165, D:K.165, D:R.273
- pi-Stacking: D:F.301
ATP.16: 21 residues within 4Å:- Chain E: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, D.251, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.15
13 PLIP interactions:13 interactions with chain E- Hydrogen bonds: E:Y.131, E:G.162, E:S.163, E:G.164, E:K.165, E:S.166, E:V.167, E:Q.171, E:Y.305, E:Y.369
- Salt bridges: E:K.165, E:K.165, E:R.273
ATP.18: 21 residues within 4Å:- Chain F: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, D.251, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.17
13 PLIP interactions:13 interactions with chain F- Hydrogen bonds: F:Y.131, F:G.162, F:G.164, F:K.165, F:S.166, F:V.167, F:Q.171, F:Y.305, F:Y.369
- Salt bridges: F:K.165, F:K.165, F:R.273
- pi-Stacking: F:F.301
ATP.22: 21 residues within 4Å:- Chain G: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, D.251, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.21
13 PLIP interactions:13 interactions with chain G- Hydrogen bonds: G:Y.131, G:G.162, G:S.163, G:G.164, G:K.165, G:S.166, G:V.167, G:Q.171, G:Y.305, G:Y.369
- Salt bridges: G:K.165, G:K.165, G:R.273
ATP.24: 21 residues within 4Å:- Chain H: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, D.251, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.23
13 PLIP interactions:13 interactions with chain H- Hydrogen bonds: H:Y.131, H:G.162, H:G.164, H:K.165, H:S.166, H:V.167, H:Q.171, H:Y.305, H:Y.369
- Salt bridges: H:K.165, H:K.165, H:R.273
- pi-Stacking: H:F.301
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, W. et al., Mechanistic insights into CED-4-mediated activation of CED-3. Genes Dev. (2013)
- Release Date
- 2013-10-23
- Peptides
- Cell death protein 4: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 4.20 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x PRO- LEU- PHE- ASN- PHE- MSE- GLY: CED-3 fragment(Non-covalent)
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, W. et al., Mechanistic insights into CED-4-mediated activation of CED-3. Genes Dev. (2013)
- Release Date
- 2013-10-23
- Peptides
- Cell death protein 4: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B